Rapid SDH vs HALO
AI Verdict
Choose Rapid SDH if…
Choose Rapid SDH if your priority is the ultra-rapid detection of suspected acute and chronic subdural hematomas on non-contrast CT scans, delivering notifications in under a minute to accelerate neurocritical care decisions. This tool is particularly well-suited for trauma centers and emergency departments needing to quickly identify SDHs as part of a comprehensive hemorrhagic and trauma care assessment.
View Rapid SDH →Choose HALO if…
Choose HALO if your primary need is AI-powered clinical support for the rapid detection of large vessel occlusions and intracerebral hemorrhage, including volume quantification, in acute stroke patients. This solution is ideal for stroke centers requiring timely notifications, remote review capabilities, and a robust triage function to optimize acute stroke diagnosis and management pathways.
View HALO →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid SDHRapid SDH, as part of the broader RapidAI platform, benefits from features like 'Navigator Pro' which simplifies PACS navigation, automates structured reports, and pre-fetches studies, enhancing overall workflow efficiency for radiologists. While HALO offers an intuitive mobile app and fast DICOM streaming for remote review, RapidAI's ecosystem appears to provide more comprehensive workflow integration and automation features.
Clinical Value
Rapid SDHRapid SDH boasts an exceptionally high positive predictive value (PPV) of 99% (93% sensitivity, 99% specificity) for SDHs >1ml, with notifications delivered in under a minute, as confirmed by FDA clearance and clinical studies. While HALO offers strong LVO detection (91.1% sensitivity, 87.0% specificity) and ICH volume quantification, Rapid SDH's specific, high-accuracy metrics and rapid notification time for its target condition are particularly compelling.
Pricing & Value
Rapid SDHNeither tool provides fully transparent pricing. However, RapidAI offers a starting price point of approximately $12,000 for a single module in the US and highlights that some of its products, like Rapid LVO, qualify for New Technology Add-on Payment (NTAP) reimbursement, demonstrating a clearer financial value proposition. HALO's value is articulated through projected societal savings from its implementation, but lacks specific pricing details.
Enterprise Readiness
Rapid SDHRapidAI explicitly offers both cloud-based and on-premise deployment options, providing greater flexibility for diverse enterprise IT environments. The company also details robust enterprise features such as unlimited scalability, minimal hardware requirements, seamless upgrades, and end-to-end integration with PACS, RIS, and EMR, supported by a larger global footprint.
Innovation
Rapid SDHRapidAI demonstrates a broader innovative footprint with its comprehensive suite of neurovascular solutions, including stroke, trauma, and aneurysm care, and its CADx FDA clearance for Rapid ASPECTS, which improves diagnostic accuracy for less experienced readers. While Nico.Lab's expansion into other acute conditions like Aortic Dissection and Pulmonary Embolism on a single platform is innovative, RapidAI's established leadership and breadth of solutions in neuroimaging give it a slight edge.
Support & Docs
TieBoth RapidAI and Nico.Lab offer comprehensive customer support, including 24/7 multi-lingual assistance, dedicated technical services, and various forms of documentation and training. Without direct comparative user feedback on the quality or depth of these services, it is difficult to distinguish a clear winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid SDH | HALO |
|---|---|---|
| Name | Rapid SDH | HALO |
| Company | RapidAI (formerly iSchemaView) | Nico.Lab B.V. |
| Description | FDA-cleared AI module that rapidly detects suspected acute and chronic subdural hematomas on CT scans, delivering notifications in under a minute to accelerate neurocritical care decisions. | AI-powered, cloud-based clinical support tool for the rapid detection of large vessel occlusions and intracerebral hemorrhage in acute stroke patients, providing timely notifications to medical specialists. |
| Key Detections | Suspected hemispheric acute and chronic subdural hematoma (SDH) | Large Vessel Occlusion (LVO), Intracerebral Hemorrhage (ICH) and volume quantification |
| Notification Time | One minute or less | Timely notifications |
Videos
Demos, reviews, and walkthroughs featuring Rapid SDH and HALO.